Literature DB >> 20130046

Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection.

Jennifer H Huch1, Anthony L Cunningham, Ann M Arvin, Najla Nasr, Saskia J A M Santegoets, Eric Slobedman, Barry Slobedman, Allison Abendroth.   

Abstract

Varicella-zoster virus (VZV) causes varicella and herpes zoster, diseases characterized by distinct cutaneous rashes. Dendritic cells (DC) are essential for inducing antiviral immune responses; however, the contribution of DC subsets to immune control during natural cutaneous VZV infection has not been investigated. Immunostaining showed that compared to normal skin, the proportion of cells expressing DC-SIGN (a dermal DC marker) or DC-LAMP and CD83 (mature DC markers) were not significantly altered in infected skin. In contrast, the frequency of Langerhans cells was significantly decreased in VZV-infected skin, whereas there was an influx of plasmacytoid DC, a potent secretor of type I interferon (IFN). Langerhans cells and plasmacytoid DC in infected skin were closely associated with VZV antigen-positive cells, and some Langerhans cells and plasmacytoid DC were VZV antigen positive. To extend these in vivo observations, both plasmacytoid DC (PDC) isolated from human blood and Langerhans cells derived from MUTZ-3 cells were shown to be permissive to VZV infection. In VZV-infected PDC cultures, significant induction of alpha IFN (IFN-alpha) did not occur, indicating the VZV inhibits the capacity of PDC to induce expression of this host defense cytokine. This study defines changes in the response of DC which occur during cutaneous VZV infection and implicates infection of DC subtypes in VZV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130046      PMCID: PMC2849518          DOI: 10.1128/JVI.01450-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions.

Authors:  Gianni Gerlini; Giulia Mariotti; Beatrice Bianchi; Nicola Pimpinelli
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

2.  Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin.

Authors:  Edouard Begon; Laurence Michel; Béatrice Flageul; Isabelle Beaudoin; Francette Jean-Louis; Hervé Bachelez; Louis Dubertret; Philippe Musette
Journal:  Eur J Dermatol       Date:  2007-10-19       Impact factor: 3.328

Review 3.  Varicella.

Authors:  Ulrich Heininger; Jane F Seward
Journal:  Lancet       Date:  2006-10-14       Impact factor: 79.321

Review 4.  Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses.

Authors:  Zheng Zhang; Fu Sheng Wang
Journal:  Cell Mol Immunol       Date:  2005-12       Impact factor: 11.530

5.  Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells.

Authors:  Kristina Larsson; Malin Lindstedt; Carl A K Borrebaeck
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

6.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 7.  Human dendritic cell line models for DC differentiation and clinical DC vaccination studies.

Authors:  Saskia J A M Santegoets; Alfons J M van den Eertwegh; Arjan A van de Loosdrecht; Rik J Scheper; Tanja D de Gruijl
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

8.  Image-based study of interferongenic interactions between plasmacytoid dendritic cells and HSV-infected monocyte-derived dendritic cells.

Authors:  Nicholas J Megjugorac; Evan S Jacobs; Alexander G Izaguirre; Thaddeus C George; Gunjan Gupta; Patricia Fitzgerald-Bocarsly
Journal:  Immunol Invest       Date:  2007       Impact factor: 3.657

9.  Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.

Authors:  Sara J Conry; Kimberly A Milkovich; Nicole L Yonkers; Benigno Rodriguez; Helene B Bernstein; Robert Asaad; Frederick P Heinzel; Magdalena Tary-Lehmann; Michael M Lederman; Donald D Anthony
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

10.  Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha.

Authors:  Gianni Gerlini; Giulia Mariotti; Alberto Chiarugi; Paola Di Gennaro; Roberto Caporale; Astrid Parenti; Leonardo Cavone; Adrian Tun-Kyi; Francesca Prignano; Riccardo Saccardi; Lorenzo Borgognoni; Nicola Pimpinelli
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

View more
  32 in total

1.  Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.

Authors:  Cindy Gutzeit; Martin J Raftery; Matthias Peiser; Karsten B Tischer; Martina Ulrich; Melanie Eberhardt; Eggert Stockfleth; Thomas Giese; Andreas Sauerbrei; Craig T Morita; Günther Schönrich
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

2.  Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Authors:  Megan Steain; Barry Slobedman; Allison Abendroth; Jarrod J Kennedy
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

Review 3.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

4.  Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs.

Authors:  Kristen Haberthur; Christine Meyer; Nicole Arnold; Flora Engelmann; Daniel R Jeske; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 5.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

6.  In vivo confocal microscopy detects bilateral changes of corneal immune cells and nerves in unilateral herpes zoster ophthalmicus.

Authors:  Bernardo M Cavalcanti; Andrea Cruzat; Afsun Sahin; Deborah Pavan-Langston; Eric Samayoa; Pedram Hamrah
Journal:  Ocul Surf       Date:  2017-09-18       Impact factor: 5.033

Review 7.  Varicella zoster virus immune evasion strategies.

Authors:  Allison Abendroth; Paul R Kinchington; Barry Slobedman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

8.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

9.  Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Authors:  Tihana Lenac Roviš; Susanne M Bailer; Venkata R Pothineni; Werner J D Ouwendijk; Hrvoje Šimić; Marina Babić; Karmela Miklić; Suzana Malić; Marieke C Verweij; Armin Baiker; Orland Gonzalez; Albrecht von Brunn; Ralf Zimmer; Klaus Früh; Georges M G M Verjans; Stipan Jonjić; Jürgen Haas
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

10.  Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections.

Authors:  Karin Vogel; Sabrina Thomann; Benjamin Vogel; Philipp Schuster; Barbara Schmidt
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.